Choate Investment Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,654
Closed -$249K 383
2024
Q1
$249K Hold
3,654
0.01% 357
2023
Q4
$229K Buy
+3,654
New +$229K 0.01% 345
2021
Q3
Sell
-1,704
Closed -$276K 311
2021
Q2
$276K Buy
+1,704
New +$276K 0.02% 236